5 Risks in Life Science M&A Transactions: Mitigation Strategies

3 min read

A scientist juggles with elixir bottles, digital art

Are you prepared to mitigate the top 5 risks in life science M&A transactions? Learn how now The life science business is continually developing and evolving, and mergers and acquisitions (M&A) transactions are one of the primary drivers of this growth. In recent years, the life science industry has experienced a surge in M&A activity as businesses seek to consolidate their positions, extend their services, and gain access to new markets. As the sector evolves, we may anticipate more M&A activity in future years. But, like every M&A transaction, these transactions are not without risk. This article will discuss five significant…...

This article is free to read

Login to read the full article


By subscribing to our main site, you will also be subscribed to DDIntel - our regular letter showcasing our featured articles and applications.

Flavio Aliberti Flavio Aliberti brings with him a 23-year track record in consulting around business intelligence, change management, strategy, M&A transformation, IT and SOX auditing for high regulated domains, like Insurance, Airlines, Trade Associations, Automotive, and Pharma. He holds an MSc in Space Aeronautic Engineering from the University of Naples and an MSc in Advanced Information Technology and Business Management from the University of Wales.